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a b s t r a c t 
Cognitive and behavioral disabilities in preterm infants, even without obvious brain injury on conventional neuroimaging, underscores a critical need to identify the 
subtle underlying microstructural and biochemical derangements. The gamma-aminobutyric acid (GABA) and glutamatergic neurotransmitter systems undergo rapid 
maturation during the crucial late gestation and early postnatal life, and are at-risk of disruption after preterm birth. Animal and human autopsy studies provide the 
bulk of current understanding since non-invasive specialized proton magnetic resonance spectroscopy ( 1 H-MRS) to measure GABA and glutamate are not routinely 
available for this vulnerable population due to logistical and technical challenges. We review the specialized 1 H-MRS techniques including MEscher-GArwood Point 
Resolved Spectroscopy (MEGA-PRESS), special challenges and considerations needed for interpretation of acquired data from the developing brain of preterm infants. 
We summarize the limited in-vivo preterm data, highlight the gaps in knowledge, and discuss future directions for optimal integration of available in-vivo approaches 
to understand the influence of GABA and glutamate on neurodevelopmental outcomes after preterm birth. 
1. Introduction 
The lifelong burden of neurodevelopmental impairment in survivors 
of premature birth is a major public health challenge with more than 
50% of very preterm infants [born before 32 weeks gestational age (GA)] 
dependent on complex healthcare, specialized education and social sup- 
port; and thus limiting quality of life. ( Laptook et al., 2005 ; Hintz et al., 
2015 ; Gire et al., 2018 ) In fact, even the relatively mature moderate-to- 
late (32–36 weeks GA) preterm infants, who are usually free of obvious 
brain injury on conventional neuroimaging, have a two-fold increased 
risk for cognitive and behavioral impairments compared with term-born 
infants. ( Eeles et al., 2017 ; van Baar et al., 2009 ; Cserjesi et al., 2012 ; 
Spittle et al., 2017 ; Johnson et al., 2015 ) This underscores a critical 
need to identify the subtle but pervasive microstructural and biochem- 
ical derangements in the developing brain prematurely exposed to the 
extra-uterine environment. 
Mid-to-late gestation is a rapid phase of neuronal organization 
and maturation of the principal neurotransmitter systems involving 
gamma-amino butyric acid (GABA) and glutamate. ( G Xu et al., 2011 ; 
Volpe, 2017 ) The balance between the inhibitory GABA and excitatory 
glutamate signals are central to pathophysiology of several pediatric 
and adult neurologic disorders, which occurs more often in individu- 
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als born prematurely. ( Horder et al., 2018 ; G. Ende, 2015 ; Ream and 
Lehwald, 2018 ) GABA-ergic signaling undergoes developmentally reg- 
ulated transitions, ( Ben-Ari, 2018 ; Tyzio et al., 2006 ; Ben-Ari, 2014 ) 
which in conjunction with synchronized glutamatergic system matura- 
tion, is crucial for normal brain development. Animal and human au- 
topsy studies have reported microstructural and functional disruption 
of GABA and glutamatergic system following preterm birth which may 
explain the neurodevelopmental impairments even in absence of major 
injury on conventional neuroimaging. 
Non-invasive neuroimaging using head ultrasound or magnetic res- 
onance imaging (MRI) allow for longitudinal assessment of structural 
brain growth, but advanced tools are needed to specifically assess the 
development of the GABA and glutamatergic system. Proton magnetic 
resonance spectroscopy ( 1 H-MRS) allows in-vivo measurement of neu- 
rometabolites; however, reliable measurement of GABA and glutamate 
concentrations in preterm infants is hindered by challenges as reviewed 
further. ( G Xu et al., 2011 ; GE Dwyer et al., 2018 ; Mullins et al., 2014 ) 
First, we summarize the neurophysiologic significance of the GABA and 
glutamatergic system and its developmental timeline during late ges- 
tation and early postnatal period based largely on animal or ex-vivo 
human studies. Then, we will review the 1 H-MRS methods used in adult 
studies, the technical challenges in their application in preterm infants, 
and the limited data from studies investigating the developing preterm 
https://doi.org/10.1016/j.neuroimage.2021.118215 . 
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brain. Finally, we discuss special considerations for interpretation of the 
available data, gaps in current knowledge and future directions to inte- 
grate in-vivo tools for a comprehensive understanding of the GABA and 
glutamate systems in the preterm brain. 
2. GABA and glutamate in the developing brain: ex-vivo data 
2.1. The critical role of GABA and glutamate in brain development 
GABA and glutamate, the principal inhibitory and excitatory neuro- 
transmitters respectively in the mature human brain, act via ionotropic 
(GABA A, AMPA and NMDA) and metabotropic (G-coupled GABA B and 
glutamate) receptors. ( Volpe, 2017 ; Wu and Sun, 2015 ; Petroff, 2002 ) 
In the developing brain, in addition to neurotransmission, they play 
a crucial role in neuronal migration, differentiation, dendrite and 
synapse formation and organization of neural circuits. ( G Xu et al., 
2011 ; Volpe, 2017 ; Huang et al., 2007 ; Cellot and Cherubini, 2013 ; 
Gaiarsa et al., 2011 ) GABA and glutamate system maturation in- 
volves developmentally synchronized neuronal migration and organi- 
zation, perinatal ion-channel transitions, synapse and dendrite matura- 
tion, followed by pruning extending through the early childhood and 
adolescence. ( G Xu et al., 2011 ; Ben-Ari, 2014 ; Wu and Sun, 2015 ; 
Huang et al., 2007 ; Ben-Ari et al., 2012 ; Kilb, 2012 ; Demarque et al., 
2002 ; Smyser et al., 2010 ; Represa and Ben-Ari, 2005 ) 
GABA and glutamate are located in cytoplasmic, vesicular (synap- 
tic) and extracellular pools, each with distinct roles and patho- 
physiologic relevance. ( Volpe, 2017 ; Petroff, 2002 ) The cytoplasmic 
pool primarily plays metabolic role; whereas vesicular neurotransmit- 
ters are found in high concentrations within the pre-synaptic bou- 
tons and mediates synaptic neurotransmission. ( Wu and Sun, 2015 ; 
Petroff, 2002 ; Kilb, 2012 ; Martin and Rimvall, 1993 ; Belelli et al., 
2009 ; Maddock et al., 2016 ; Ito, 2016 ) There is significant turnover 
and cycling among the pools with the extrasynaptic pool contribut- 
ing upto 70% of the total brain tissue GABA. ( Petroff, 2002 ) Dur- 
ing early development, a substantial part of GABAergic transmission 
may occur via non-synaptic processes. ( Demarque et al., 2002 ) In 
fact, the tonic GABA A -mediated membrane depolarization provides the 
first excitatory drive necessary for promoting neurite outgrowth and 
synapse formation as well as chemotropic action on cell migration. 
( Cellot and Cherubini, 2013 ; Demarque et al., 2002 ; Demarque et al., 
2002 ; Demarque et al., 2002 ) GABA plays tonic, neuromodulatory 
role in cortical inhibition, via free extracellular GABA acting on extra- 
synaptic GABA A receptors. ( Belelli et al., 2009 ) Further, GABA exerts 
metabotropic action via GABA B receptors, contributing to cell survival, 
migration, differentiation, as well as to the maturation and plasticity 
of developing synaptic connections. ( Gaiarsa et al., 2011 ) Interestingly, 
the presynaptic GABA B mediated control of transmitter release devel- 
ops early and regulates neuronal growth before the conventional post 
synaptic GABA B mediated inhibition is established; ( Gaiarsa et al., 2011 ) 
emphasizing the importance of developmental timeline and its potential 
disruption after preterm birth. 
GABA and glutamate metabolic pathways are interconnected with 
glutamine being a common precursor involving cyclical turnover within 
synthetic, re-uptake and breakdown pathways and regulated transport 
across neurons and glial cells, suggesting multiple levels of intertwined 
neuromodulatory roles. ( Petroff, 2002 ) Further, GABA-mediated large 
membrane depolarizations have been shown to facilitate glutamatergic 
signaling as well as regulate the formation of glutamatergic synapses 
in the developing cortex in vivo with contribution of NMDA receptors. 
( Ito, 2016 ; Mohajerani and Cherubini, 2006 ; Kasyanov et al., 2004 ) This 
emphasizes the importance of their simultaneous investigation in the 
developing brain. 
2.2. Late gestation and early postnatal timeline of GABA and glutamate 
system micro-structural development 
Glutamatergic and a majority of GABAergic neurons originate in the 
fetal dorsal telencephalic zone and migrate along radial glia fibers early 
in gestation to reach the developing cortical subplate and eventually 
neocortex by third trimester. ( G Xu et al., 2011 ; Rakic and Sidman, 1970 ; 
Rymar and Sadikot, 2007 ; Letinic et al., 2002 ) This synchronized neu- 
ronal migration declines by term age and is completed by 6 postnatal 
months; ( G Xu et al., 2011 ) in parallel with increasing GABAergic neu- 
ronal density in the cortex during late gestation and reaching a peak at 
term age. Hence in the event of preterm birth during the 2nd trimester, 
some neurons may still be migrating through the white matter; as some 
GABA-ergic neurons have been reported in the cerebral white matter 
as late as 31 gestational weeks. ( Rakic and Sidman, 1970 ) From mid- 
gestation to infancy, the GABA A receptor and glutamic acid decarboxy- 
lase enzyme (GAD65 and GAD67, synthesizing synaptic and cytoplasmic 
GABA respectively) measures increase in the cortical middle laminae; in 
line with the striking increase in thickness of layers I-III after 30 weeks 
gestation; likely reflecting expansion by migrated GABAergic interneu- 
rons. ( Volpe, 2017 ; Rakic and Sidman, 1970 ) A similar increase in glu- 
tamate levels during late gestational period, followed by a 25% decline 
due to apoptosis and then a gradual increase into young adulthood has 
been described in mouse parietal cortex. ( Benitez-Diaz et al., 2003 ) The 
GABA-ergic interneurons provide most of the early regulatory signals 
modulating neuronal growth esp glutamatergic pyramidal cell growth 
and organization in the developing cortex. ( Chen and Kriegstein, 2015 ; 
Khazipov et al., 2001 ; Tyzio et al., 1999 ) The last trimester of human 
gestation and early postnatal life is also a period of rapid axonal de- 
velopment, oligodendrocyte proliferation, dendritogenesis, and synapse 
formation; ( Volpe, 2017 ; Rymar and Sadikot, 2007 ) which remain is at 
risk of disruption after preterm birth. 
2.3. Preterm birth and postnatal exposures alter GABA and glutamatergic 
pathway 
McClendon et al. reported marked abnormalities in medium spiny 
projection neurons in the caudate nucleus of preterm sheep after in- 
utero global cerebral hypoxia ischemia. ( McClendon et al., 2014 ) Shaw 
et al. demonstrated decreased GAD and lower mRNA levels of 𝛼6 and 
𝛿 subunits of GABA A receptors in the cerebellum of preterm guinea 
pigs. ( Shaw et al., 2018 ; JC Shaw et al., 2015 ) Malik et al. ob- 
served suppressed glutamatergic neurogenesis in preterm rabbits pups. 
( Malik et al., 2013 ) In an ex-vivo human autopsy study, Robinson et al. 
( Robinson et al., 2006 ) reported loss of caudate nucleus GABAergic neu- 
ron expression in preterm neonates’ brains with white matter lesions. 
Several medications including opioids, sedatives and caffeine are ad- 
ministered uring postnatal intensive care and are known to influence 
GABA and glutamatergic systems as well as impact neurodevelopmental 
outcomes. ( Steinhorn et al., 2015 ; Isokawa, 2016 ; Ruangkittisakul et al., 
2015 ; Wikstrom et al., 2018 ; Duerden et al., 2016 ; Schuurmans et al., 
2015 ) 
2.4. Perinatal GABA-ergic signal transition: neuroprotective implications 
following premature birth 
GABA A receptors are ligand-gated chloride ion (Cl 
− ) channels which 
on activation, allow the passage of Cl - ions dependent on the neuronal 
transmembrane Cl - gradient. In the mature brain, intraneuronal Cl − lev- 
els are maintained at a low level by the KCC2 co-transporter channels 
(and other mechanisms) by extruding Cl − into the extracellular space; 
( Farrant and Kaila, 2007 ; Rivera et al., 1999 ) and GABA A receptor acti- 
vation allows intracellular Cl − influx, resulting in hyperpolarization and 
its inhibitory effect. ( Farrant and Kaila, 2007 ) Ex-vivo studies on the 
immature mice brain indicate that a reverse Cl − ion gradient (intracel- 
lular Cl - high) is maintained by the NKCC1 transporter and low expres- 
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sion of the KCC2 co-transporter; ( Ben-Ari, 2014 ; Ben-Ari et al., 2012 ; 
Ben-Ari et al., 2007 ) , allowing Cl − efflux after GABA A receptors acti- 
vation and resulting in a depolarizing response instead. In fact, this re- 
versed GABA signal has also been observed during pathologic states like 
epilepsy and traumatic brain injury; ( Ben-Ari et al., 2012 ) and may be 
relevant in the preterm brain, where the extra-uterine hypoxic-ischemic 
stress may alter neurosignalling and further disrupt brain development. 
The perinatal transition of Cl − channels is mediated by the oxy- 
tocin surge during labor, ( Ben-Ari, 2018 ; Tyzio et al., 2006 ) and may 
underlie the neuroprotective anti-apoptotic effect of vaginal delivery, 
compared with Ceasarean delivery. ( Castillo-Ruiz et al., 2018 ) Further, 
Shaw et al. reported increase in mRNA level of GABA A receptor sub- 
units during the fetal-to-neonatal transition following term birth; but not 
following preterm birth. ( JC Shaw et al., 2015 ) GABA A receptors have 
binding sites for the neuro-steroid allopregnanolone receptor, and may 
mediate its neuroprotective role in reducing anoxic injury and neuronal 
stress during labor. ( Ben-Ari, 2018 ; Tyzio et al., 2006 ) Erythropoietin, 
a promising neuroprotective agent, upregulates KCC2 chloride channels 
after birth following prenatal hypoxia-ischemia. ( Jantzie et al., 2014 ) 
2.5. Glutamate receptor transitions, role in apoptosis, and excitotoxic 
neuronal injury following perinatal hypoxia-ischemia 
Glutamate is expressed early during brain development, its re- 
ceptors undergo developmentally regulated transitions and plays es- 
sential role in activity-dependent plasticity and synaptic refinement. 
( Demarque et al., 2002 ; McDonald and Johnston, 1990 ; Liguz- 
Lecznar et al., 2015 ; Desfeux et al., 2010 ; Lujan et al., 2005 ) Both gluta- 
matergic receptor activation (NMDA) and antagonism have been impli- 
cated in augmenting excitotoxic and apoptotic neuronal injury respec- 
tively. ( McDonald and Johnston, 1990 ; Kaindl and Ikonomidou, 2007 ) 
In fact, NMDA receptor mediated excitotoxic injury is known to play a 
central role in hypoxic-ischemic brain injury in term neonates and may 
also play a critical role before, during and after preterm birth which of- 
ten is associated with intermittent hypoxia-ischemia. ( Johnston et al., 
2001 ; Low et al., 2003 ) 
Thus, perinatal stress may alter these developmentally regulated 
transitions especially in absence of labor before preterm birth and/or 
may unleash potentially excitotoxic events following perinatal hypoxia- 
ischemia which remains undetected by conventional neuroimaging, but 
predispose to cognitive deficits. 
3. Advanced neuroimaging: in-vivo tools for investigating GABA 
and glutamate systems 
MRI allows non-invasive assessment of structural brain growth and 
its alterations after premature birth. Longitudinal volumetric and mor- 
phometric MRIs of human fetal brain show a 4-fold increase in cor- 
tical volume and a dramatic increase in surface gyrification between 
28 and 40 weeks of post-menstrual age (PMA), which parallels the 
GABA and glutamatergic neuronal migration and cortical organization 
observed in ex-vivo studies. Standard 1 H-MRS enables measurement of 
neurometabolites like N-acetyl-aspartate (NAA), choline (Cho) creatine 
(Cr), lactate (Lac) and inositol (Ins) in the preterm brain, and their 
alterations have been associated with neurodevelopmental outcomes. 
( Card et al., 2013 ) However, these dominant metabolite signals over- 
lap the smaller signals from GABA and glutamate necessitating special- 
ized techniques for reliable measurement. ( Fig. 1 , Mullins et al., 2014 , 
GE Dwyer et al., 2018 , Kreis et al., 2002 ) 
3.1. Technical challenges with in-vivo quantification of GABA and 
glutamate by 1 H-MRS 
Glutamate concentrations in the adult human brain range from 3 to 
10 mM. Specialized techniques, including higher magnetic fields, echo- 
time (TE)-averaging and ultra-short Stimulated Echo Acquisition Mode 
(STEAM) sequence, have been used for optimal resolution of the gluta- 
mate signal. ( GE Dwyer et al., 2018 ; Ramadan et al., 2013 ; Tkac et al., 
2001 ) Nonetheless, on lower magnetic field strengths (1.5–3 T), the glu- 
tamate signal is overlapped by glutamine and therefore most publica- 
tions report the composite glutamate + glutamine (Glx) signal at 2.2–
2.5 ppm. ( Ramadan et al., 2013 ) However, measuring in-vivo GABA has 
been more challenging due to lower concentrations (1–2 mM), which 
are overlapped by signals from creatine at 3 ppm and NAA at 2.2 
and 1.9 ppm on the 1.5–3 T 1 H-MRS ( Fig 1 a). ( Mullins et al., 2014 ; 
Mikkelsen et al., 2017 ; AD Harris et al., 2017 ; Chang et al., 2003 ) Ultra- 
high magnetic field strength (7–9 T) scanners help increase the spectral 
resolution and measure GABA concentrations in animal studies. ( I Tkac 
et al., 2003 ; J Ramu et al., 2016 ) For human studies using clinical (3 
T) scanners, specialized 1 H-MRS acquisitions with shorter echo-time 
or spectral editing techniques have been used. ( Mullins et al., 2014 ; 
GE Dwyer et al., 2018 ; Shungu et al., 2016 ; G. Ende, 2015 ) Among spec- 
tral editing techniques, MEscher-GArwood Point Resolved Spectroscopy 
(MEGA-PRESS) and MEGA-sLASER have been used in adult human stud- 
ies, in which two sets of spectra are acquired with editing frequency 
pulses at 1.9 ppm (ON) and 7.5 ppm (OFF). The ON and OFF spectra 
are then subtracted to remove overlapping signals and unmask the J- 
coupled signals from GABA ( Fig. 1 b). ( Mullins et al., 2014 ; GE Dwyer 
et al., 2018 ; Puts et al., 2018 ) Nonetheless, contamination of GABA sig- 
nal at 3 ppm by the co-edited macromolecule (MM) signal remains a 
major challenge. Techniques to address MM contamination, include ac- 
quiring a metabolite-nulled MM spectrum and using it as prior knowl- 
edge during analysis and acquiring MM suppressed J-difference data; 
and have their own drawbacks like increasing acquisition time or re- 
ducing GABA signal. Hence, the convention is to report the GABA signal 
acquired using J-difference method as GABA + indicating MM contribu- 
tion. ( Mullins et al., 2014 ) 
We performed a literature search for English language publications 
in Pubmed, MEDLINE and Google Scholar using combinations of the 
key words ‘GABA, glutamate, magnetic resonance spectroscopy, new- 
born, neonate and premature’. We reviewed in detail all manuscripts 
reporting GABA (and/or glutamate) measurements using j-edited 1 H- 
MRS on infants less than 6 months age including preterm infants. We 
have briefly reviewed several studies that acquired PRESS sequence on 
a 1.5 T scanner and reported glutamate measurements from preterm 
or term newborns suffering from cerebral hypoxia. Outside of the new- 
born/preterm studies, we have summarized some of the peer-reviewed 
articles describing age and maturational aspects of GABA and/or gluta- 
mate 1 H-MRS measurements from the animal, pediatric and adult hu- 
man populations. More thorough review of 1 H-MRS studies in older chil- 
dren and adults have been published recently. ( GE Dwyer et al., 2018 ; 
Porges et al., 2020 ; AD Harris et al., 2017 ) 
4. In-vivo 1 H-MRS measurement of GABA and glutamate in the 
developing animal brain 
Ultra-high magnetic field (7–9 T) 1 H-MRS under general anesthesia 
has been used to measure GABA and glutamate concentrations in the 
developing rat brain ( Table 1 ). Tkac et al. ( I Tkac et al., 2003 ) reported 
longitudinal metabolite profile of rat brain between 7 and 28 postnatal 
days (PND), corresponding to early human brain development from 34 
weeks of gestation to 2–3 years after birth. ( BD Semple et al., 2013 ) 
Ultrashort echo-time STEAM sequences from voxels placed in the hip- 
pocampus, the striatum, and the cerebral cortex demonstrated increas- 
ing glutamate and glutamine concentrations across all regions. The ratio 
of Glu/Gln peaked between PND 14 and 21, with regional variations. 
GABA concentrations increased from PND 7 to peak around PND 14, 
and then declining slightly by PND 28. 
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Fig. 1. Representative 1 H-MRS spectrum on (a) standard PRESS and (b) MEGA-PRESS on 3T showing distinct signal peaks for GABA and Glx. 1 
Table 1 
Summary of 1 H-MRS studies measuring GABA and glutamate in the developing animal brain. 
Study 
1 H-MRS field 
strength and 
sequence 
Subjects and Study 
design Brain voxel region GABA findings Glutamate findings 
Tkac et al., 2003. 
( I Tkac et al., 2003 ) 
9.4T, Ultrashort 
echo-time STEAM 
(TE = 2 ms) 
8 rat pups, 1 H-MRS 
on PND 7, 10, 14, 
21, and 28 
Hippocampus, the 
striatum, and the 
cerebral cortex 
GABA (range 
0.7–1.1 μmol/g); ↑ from 
PND 7 to peak at PND 14 
and then slightly ↓ by PND 
28 
Glutamate ↑ ( > 0.10 μmol g − 1 
day − 1 , from 3.2 to 3.5 to 
8.7–11.2 μmol/g) between 
PND 14 to 28. Glu/Gln-ratio ↑ 
from 2.0 to 4.5 by PND 21 
Morgan et al., 
2014. ( JJ Morgan 
et al., 2013 ) 
7T, PRESS 
(TE = 20 ms, 
TR = 1250–8000 ms 
with T1 relaxation 
correction) 
9 male rats, 
1 H-MRS on PND 7, 
35, and 60 
Forebrain, centered 
on the striatum 
NA Glx ↑ between P7 
(5.38 ± 0.77 μmol/g) to P35 
(8.96 ± 0.79 μmol/g) and 
further at P60 
(10.4 ± 0.86 μmol/g) 
Ramu et al., 2016. 
( J Ramu et al., 
2016 ) 
7T, PRESS 
(TE = 8 ms) 
10 male rats, 
1 H-MRS on PND 
14–70 
Anterior cingulate 
cortex and the left 
dorsal 
hippocampus 
GABA levels remained 
stable in hippocampus 
(2.06 μmol/g, 
+ 0.002 μmol/g/day) and 
the anterior cingulate 
cortex (2.27 μmol/g, 
− 0.005 μmol/g/day). 
Glutamate levels ↑ 
(8.4–8.8 μmol/g, 
+ 0.031 μmol/g/day) in both 
regions. Gln-levels marginally 
↑ (2.3–3.1 μmol/g, 
+ 0.01 μmol/g/day) 
Raman et al., 2005. 




(TE = 2 ms, 
TM = 20 ms, 
TR = 5 s) 
23 rat pups 
exposed to chronic 
hypoxia (10% O2 
from PND 3 to 
P28), 14 normoxic 
controls 
Left hippocampus GABA levels remained 
stable longitudinally, ↑ in 
hypoxic rat pups 
Gln-levels ↑ longitudinally, 
whereas Glu/Gln-showed 
slight ↓ between P 21 and 
P28.Glu/Gln-ratio ↑ , whereas 
Gln-levels were ↓ in hypoxic 
rats 
Traudt et al., 2012. 
( Traudt et al., 
2012 ) 




(TE = 2 ms, TR = 5 s) 
Twice daily 
2 mg/kg morphine 
( n = 25) or normal 
saline ( n = 20) 
from PND 3 to 7; 
1 H-MRS on PND 8 
Left hippocampus ↓GABA (–28%) and GAD 
enzyme levels in morphine 
group 
Glu, Gln-levels were 
unchanged 
Using 7T PRESS sequences, Morgan et al. ( JJ Morgan et al., 2013 ) 
reported increasing Glu + Gln- concentrations in the rat forebrain be- 
tween the neonatal stage (P7) to young adulthood (P60) and Ramu et al. 
( J Ramu et al., 2016 ) reported slight increase in Glu- levels and stable 
GABA levels between PND 14 and 35 in the left dorsal hippocampus and 
anterior cingulate cortex of rat brain. With the caveat of anaesthetized 
scans and developmentally more complex human brain, animal data 
suggests a consistent increase in brain glutamate concentrations from 
late gestation, through the neonatal stage into adolescence and reach- 
ing a plateau in adulthood; whereas GABA concentrations remain either 
1 Footnote: Representative spectra acquired from a preterm infant at 
term corrected age from a voxel centered over the right basal ganglia 
(17 × 27 × 10 mm 3 ). The spectrum was acquired on a 3T scanner with TE = 68 ms, 
TR = 2000 ms, NSA = 256 and the editing pulses at 1.9 ppm and 7.5 ppm. 
stable or increase slightly during the early stages of brain development. 
( BD Semple et al., 2013 ; Clancy et al., 2007 ) 
5. In-vivo 1 H-MRS studies measuring GABA and glutamate in 
human brain 
5.1. Studies in healthy children and adults 
1 H-MRS studies involving healthy children and adults have reported 
age, gender and regional differences in the brain GABA and glutamate 
concentrations ( Table 2 ). Holmes et al. ( MJ Holmes et al., 2017 ) re- 
ported increase in glutamate concentrations with advancing age in the 
mid-frontal gray matter, peri ‑trigonal white matter and right basal gan- 
glia of children between 5 and 10 years of age. Saleh et al. ( Saleh et al., 
2020 ) recently reported a positive correlation between age and GABA + 
concentrations in the frontal voxel of healthy children (5–14 years). 
4 
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Table 2 
Summary of 1 H-MRS studies measuring GABA and glutamate in the mature human brain. 
Study 
1 H-MRS field 
strength and 
sequence 
Subjects and Study 
design Brain voxel region GABA findings Glutamate findings 
Holmes et al., 
2017. ( MJ Holmes 
et al., 2017 ) 
3T, PRESS 
(TR = 2000 ms, 
TE = 30 ms, 64 
averages, 2:16 min 
duration) 
64 children 5–10 
years (29 were 




peri ‑trigonal white 
matter and right 
basal ganglia 
(1.5 × 1.5 × 1.5 
cm 3 voxel) 
NA Glutamate ↑ (0.27 ± 0.06) 
with age in all regions. No 
sex-age or HIV-age 
interactions noted 
Maes et al., 2017. 
( Maes et al., 2018 ) 
3T, MEGA-PRESS 
(TE = 68 ms; 
TR = 2000 ms; 320 
averages; 2048 
points, bandwidth 
2000 Hz,11 min 
duration) 
85 young (18–35 




cortex and the 
midline occipital 
cortex (3 × 3 × 3 
cm3). Voxel tissue 
correction 
performed 
Unadjusted GABA ↓ in 
older adults. Adjusted for 
voxel CSF and white/gray 
matter, age differences 
were not significant 
NA 
Gao et al., 2013. 
( Gao et al., 2013 ) 
3T, MEGA-PRESS 
(TR = 2000 ms, 
TE = 68 ms, 
bandwidth 
1000 Hz, 320 
signal averages) 






3 × 3 × 3 cm3 
GABA + /Cr and GABA + /NAA 
were ↑ in frontal region. 
Concentrations ↓with age 
( r = − 0.6 with 4–5% decline 
per decade). ↓ in GABA 
levels with age was more 
rapid in women 
Glx/Cr ratios demonstrated 
significant ↓with age ( r = − 0.4). 
No gender effect in regional or 
age-related changes 
O’Gorman et al., 
2011. 
( O’Gorman et al., 
2011 ) 
3T, MEGA-PRESS 
(TR = 1800 ms, 
TE = 68 ms, 320 
signal averages, 
10 min duration) 
14 healthy adults 
(7 female), age 
range 25–38 years 
Dorsolateral 
prefrontal cortex. 
30 ml voxel 
(25 × 40 × 30 mm3) 
GABA concentrations were 
↑ in males. No age effect 
noted 
Glu-and Glx concentrations 
were ↑ in males; no age effect 
and no gender effect on Gln 
Grewal et al., 2016. 
( Grewal et al., 
2016 ) 
3T, MEGA-PRESS 
(TR = 2000 ms; 
TE = 68 ms; 
bandwidth 
2000 Hz; 2048 
samples; 320 
signal averages) 







(2.5 × 2.5 × 2.5 
cm3) 
Frontal cortex levels 
↓(2.09 ± 0.5 mM) than 
others (2.8 ± 0.7 mM), but 
no interhemispheric 
differences. GABA with Cr 
as internal reference 
NA 
Huang et al., 2016. 
( Huang et al., 
2017 ) 
3T, MEGA-PRESS 
(TR = 2000 ms, 
TE = 68 ms, 64 
averages, 
bandwidth 
1000 Hz, duration 
4:24 min) 
Normal adults: 17 
young and 15 
elderly; 17 adults 
with Alzheimer’s 





40 × 40 × 25 mm3) 
and right 
hippocampus (rHP; 
40 × 20 × 20 mm3) 
GABA + /Cr ratios were ↓in 
elderly adults compared 
with young adults 
Glx/Cr ratios were ↓ in elderly 
adults; with further ↓ in ACC 
in Alzheimers’ disease and 
hippocampus in adults with 
cognitive impairment. 
Van der Veen 
et al., 2013. 
( van der Veen and 
Shen, 2013 ) 
3T, MEGA-PRESS 
(TR = 1500 ms, 




range 2.0–0.6 ppm 
18 adult 
volunteers (22–57 




Voxel 3 × 3 × 2 
cm 3 
GABA/Cr ratio was 16% ↑ in 
the occipital cortex 
(0.1103 ± 0.005) compared 
with medial prefrontal 
cortex (0.095 ± 0.004) 
No regional difference in Glx. 
Choi et al. ( IY Choi 
et al., 2006 ) 
3T MR GABA CSI 
with STEMS 
13 healthy adult 
subjects 
Gray vs White 
matter using CSI 
GABA concentration in 
gray (1.30 ± 0.36 𝜇mol/g) 
and white matter 
(0.16 ± 0.16 𝜇mol/g). 
GABA/Cr ratios were ↑ in 
gray matter (0.16 ± 0.04) 
compared with white 
matter (0.03 ± 0.03). 
Hermans et al. 
( Hermans et al., 
2018 ) 
3T MEGA-PRESS 28 older (63–74 






GABA levels did not differ 
between age groups. 
Harada et al., 2011. 
( Harada et al., 
2011 ) 
3T, MEGA-PRESS 
(TR = 1500 ms,TE = 68 ms, 
256 signal averages 
15 healthy young 
adults (avg 22 
years). 8 men were 
scanned 1 week 





luteal phase of 
menstrual cycle 
Lentiform Nuclei 
(LN), left frontal 
lobe, or anterior 
cingulate Cortex 
(AC). Voxel size 
3 × 3 × 3 cm 3 
GABA level in LN 
(1.37 ± 0.34 mM) was the 
highest, and AC 
(0.79 ± 0.21 mM) was the 
lowest. Good 
reproducibility (0.72 
correlation) in men; GABA 
levels were ↑ during 
follicular phase in women 
NA 
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However, Maes et al. ( J Ramu et al., 2016 ) did not observe an age de- 
pendent change in macromolecule-suppressed GABA concentrations in 
7–14 year old healthy children, and they speculated whether the early 
increase in GABA + levels could be driven mostly by changes in co-edited 
macromolecules. 
Shimizu et al. reported lower Glu/Cr levels in frontal and occipi- 
tal cortices of young adults (18–33 years) compared to children (4–
13 years). ( Shimizu et al., 2017 ) O’Gorman et al. ( O’Gorman et al., 
2011 ) observed no age-dependent frontal and parietal GABA or Glu- 
concentration changes in healthy adults between 25 and 38 years age; 
with higher GABA and Glu-levels in males compared to females. Gao 
et al. ( Gao et al., 2013 ) reported a declining GABA and Glx/Cr level in 
healthy adults between 20 and 76 years of age; with more rapid decline 
in GABA + levels in the frontal region of women than men. A positive 
correlation of cognition with frontal GABA concentrations ( EC Porges 
et al., 2017 ) and a decline in regional GABA concentrations with ad- 
vancing age has been reported in healthy elderly population. ( EC Porges 
et al., 2017 ; Maes et al., 2018 ) In a pre-print meta-analysis, Porges et al. 
have integrated data from 8 published reports that include subjects be- 
tween the ages of 8 years to the 8th decade of life, to show a lifespan 
brain GABA trajectory in which an early period of rapid increase is fol- 
lowed by a period of stability during early adulthood, and a gradual 
decrease during adulthood and aging. ( Porges et al., 2020 ) 
Grewal et al. reported lower GABA concentrations in the frontal com- 
pared to the parietal and occipital cortices, but no interhemispheric vari- 
ations. ( Grewal et al., 2016 ) Consistently, van der Veen et al. ( van der 
Veen and Shen, 2013 ) reported higher GABA/Cr ratio in the occipital 
cortex compared with medial prefrontal cortex. Choi et al. ( IY Choi 
et al., 2006 ) reported 8-fold higher GABA concentrations and 5-fold 
higher GABA/Cr ratio in the gray matter compared with white matter 
in healthy adults. 
Functional role of the measured GABA and glutamate levels have 
been investigated by several studies. ( van der Veen and Shen, 2013 ; 
IY Choi et al., 2006 ; Hermans et al., 2018 ; Harada et al., 2011 ) Her- 
mans et al. ( Hermans et al., 2018 ) employed edited 1 H-MRS and tran- 
scranial magnetic stimulation (TMS) in the left sensorimotor cortex and 
observed that older adults (63–74 years) had reduced GABA mediated 
short and long-interval intracortical inhibition. Acute increase in GABA 
concentrations ( Coxon et al., 2018 ) and glutamate/Cr ratios following 
exercise, ( Maddock et al., 2016 ) association with default mode network 
deactivation during working memory task ( Chen et al., 2018 ) and cor- 
relation of GABA and glutamate concentrations with cognitive function 
( EC Porges et al., 2017 ; Huang et al., 2017 ) emphasizes their relevance 
in executive task performance. The importance of GABA and glutamate 
in cognitive impairment with normal aging is further highlighted by the 
findings in adults with neurologic disorders. 
5.2. Studies in subjects with neurologic disorders 
Altered GABA and glutamate concentrations have been reported 
in pediatric and adult disorders, including epilepsy, autism, attention- 
deficit disorder and schizophrenia. ( Horder et al., 2018 ; MJ Holmes 
et al., 2017 ; Bluml et al., 2013 ; G. Ende, 2015 ; Blum and Mann, 2002 ) 
A meta-analysis of 40 1 H-MRS studies reported lower brain GABA levels 
in subjects with depression and autism spectrum disorders ( Schur et al., 
2016 ) Ende et al. ( G. Ende, 2015 ; Ende et al., 2016 ) have reviewed the 
relationship between in-vivo GABA and glutamate and adult neuropsy- 
chological conditions. Impulsivity scores were positively correlated with 
Glu, and negatively correlated with GABA concentrations in adolescents. 
( Murphy et al., 2012 ; Hayes et al., 2014 ) Improved selective motor in- 
hibition was associated with increased glutamate levels in the premo- 
tor cortex of children with Tourette Syndrome, ( Mahone et al., 2018 ) 
emphasizing the importance of their role in behavior regulation. In- 
fact, in a randomized trial of bumetanide treatment in children with 
autism spectrum disorder, treatment was associated with a reduction in 
GABA/Glx ratio and symptom improvement. ( Zhang et al., 2020 ) Inter- 
estingly, neuro-behavior disorders including autism are more common 
in survivors of prematurity; which emphasizes the importance of in vivo 
investigation of GABA and glutamate changes during early postnatal life 
of preterm infants. 
5.3. Challenges in GABA and glutamate quantification by 1 H-MRS in 
neonatal/reterm populations 
The standard 1.5 T clinical neonatal MRIs have lower signal-to-noise 
ratios (SNR) and spectral resolution from a limited voxel volume due to 
relatively small brain volume in the newborn (even smaller in preterm 
infants). ( Mullins et al., 2014 ; Kreis et al., 2002 ; Grewal et al., 2016 ; 
Tanifuji et al., 2017 ; Kwon et al., 2014 ) The J-difference acquisitions for 
MEGA-PRESS to resolve GABA and glutamate peaks are time consum- 
ing and very susceptible to motion artifacts, a major limitation of non- 
sedated scans in neonates. Using sedation for research MRI studies is not 
only ethically questionable, but may also alter brain GABA and gluta- 
mate metabolism and spectroscopic signals. Motion correction strategies 
employed in adult studies include retrospective correction using navi- 
gators sequences to correct for frequency and phase variations due to 
motion. ( Andronesi et al., 2020 ) However, prospective motion correc- 
tion using navigator sequences require the use of additional interleaved 
pulse sequence, and are not widely used in neonatal acquisitions with 
additional disadvantage of increased specific absorption rate and longer 
acquisition time in these vulnerable preterm babies. Smaller preterm 
infants need an MRI-compatible transport incubator for thermoregula- 
tion, a ventilator for respiratory support, cardiorespiratory monitoring 
and intravenous infusions during the MRI scan, which emphasizes the 
importance of nursing expertise for close monitoring as well as feed and 
bundle approach to minimize motion artifacts. 
Adult studies use tissue correction strategies usually assuming negli- 
gible metabolite contribution by CSF and a relatively higher concen- 
tration of GABA and glutamate in gray (2-fold) compared to white 
matter. ( EC Porges et al., 2017 ; Harris et al., 2015 ) However in the 
preterm brain, these assumptions may not be universally applicable 
given the temporal changes in the sub-cortical plate, neuronal mi- 
gration through the white matter, ill-defined gray-white matter delin- 
eation and metabolic and functional maturation of GABA and gluta- 
matergic neurons. Additionally, evolving sulcation and gyration pat- 
terns, increasing cortical layer thickness, larger CSF to parenchymal 
volume proportions and relatively small regional brain volumes of the 
neonatal brain add challenges in application of adult (or even pedi- 
atric) anatomical segmentation atlases. Ideally, age specific brain atlases 
( Makropoulos et al., 2018 ) should be used along with implementation 
of tissue correction and motion correction strategies. ( Andronesi et al., 
2020 ; Quadrelli et al., 2016 ) Despite these challenges affecting the spec- 
tral quality, investigations including preterm infants are of utmost im- 
portance for understanding this crucial phase of brain development. 
5.4. Studies in preterm and term infants 
Till date, only a few studies have reported either GABA and/or glu- 
tamate in-vivo concentrations in the preterm brain during their early 
postnatal life. Kreis et al. ( Kreis et al., 2002 ) in 2002, reported in-vivo 
glutamate and GABA concentrations in nine preterm infants (mean GA 
of 32.7 ± 1.6 weeks) who were longitudinally scanned at PMA 32–35 
weeks and at 39–43 weeks (TEA); and 12 full term infants who were 
scanned once at 38–42 weeks PMA. Non-sedated short-TE 1 H-MRS were 
acquired on a 1.5 T scanner (TE = 20 ms, TR = 3000 ms, 128 acquisitions, 
bandwidth = 1953 Hz) from voxels placed over the thalamus, parame- 
dian occipital gray matter and centrum semiovale white matter. They 
observed significant increases in glutamate concentrations with advanc- 
ing GA in preterm infants from 3.8 ± 2.0 mM/kg at < 35 weeks PMA 
to 4.4 ± 1.2 mM/kg at TEA ( p < 0.05). However, glutamate concentra- 
tions were similar between full-term infants and preterm infants at TEA 
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(4.6 ± 1.3 vs 4.4 ± 1.2 mM/kg, p = NS). The term infants had higher con- 
centrations of glutamate in the thalamus compared with gray and white 
matter voxels ( p < 0.0001). The authors acknowledged limited resolution 
for the GABA measurements, which did not show significant age trends 
(0.1 ± 0.5 vs 0.1 ± 0.2 mM/kg, p = NS) or regional variations. Several 
reports from term infants with cerebral hypoxia-ischemia have reported 
Glx/Cho or Glx/NAA ratios using 1.5 T 1 H-MRS PRESS (TE = 30 ms) 
but did not find significant association with outcomes or diseased state. 
( Holshouser et al., 1997 ; Roelants-Van Rijn et al., 2001 ) Bluml et al. 
reported trends in Glx levels in 5 brain regions of 309 children between 
0 and 18 years age based on 1.5 T 1 H-MRS PRESS (TE = 35 ms) and re- 
ported that Glx levels peaked at approximately 4–6 months and then 
declined or reached a plateau by 1–2 years in cortical gray and sub- 
cortical white matter, with continued increase throughout the first 2 
years in the deep nuclear gray matter. ( Bluml et al., 2013 ) 
Koob et al. reported in-vivo Glx/H 2 O measures from 16 preterm (GA 
29.1 ± 2 weeks) and 16 term infants scanned at PMA 39.2 ± 1 and 
39.8 ± 1 weeks respectively. ( Koob et al., 2016 ) They used a 1.5T MR 
scanner to acquire PRESS sequence (TE = 30 ms, TR = 1500 ms, 256 aver- 
ages and TE = 135 ms, TR = 1500 ms, 278 averages) from a 4.5 cm 3 voxel 
centered at the level of the white matter underlying the central sulcus 
within the centrum semiovale. 1H-MRS spectra were acquired with wa- 
ter saturation with the chemical shift-selective module at both TEs. An 
additional spectrum was acquired at a TE of 30 ms without water satu- 
ration. At a TE of 30 ms, Glx/H2O tended to be lower in preterm cohort 
( − 20%), but relationship with GA or PMA at scan was not found to be 
statistically significant. 
Kwon et al. ( Kwon et al., 2014 ) performed 1 H-MRS at term cor- 
rected age in 20 preterm (birth weight < 1500 gs) and 25 healthy 
term control newborns (born between 37 and 41 weeks’ PMA). Using 
a 3T MRI scanner, GABA-edited MEGA-PRESS spectra were acquired 
from a 2 × 3 × 3 cm 3 voxel (TR = 1500 ms, TE = 68 ms, flip angle = 90°, 
bandwidth = 1200 Hz) localized over the right frontal region of the 
brain. They reported that the preterm infants had lower regional GABA 
(0.013 ± 0.004 vs 0.016 ± 0.004 units/mm 3 , p = 0.049) and glutamate 
(0.031 ± 0.0008 vs 0.042 ± 0.01 units/mm 3 , p = 0.005) concentra- 
tions compared with term infants. Interestingly, preterm infants showed 
a positive correlation ( r = 0.735, p = 0.01) between GABA concentra- 
tions and functional resting state intrinsic connectivity distribution in 
the right Broadman Areas BA9, BA44 and BA6, while term controls 
demonstrated a negative correlation ( r = − 0.564, p = 0.02). These frontal 
regions are involved in language and executive function and its uncer- 
tain whether the observed differences are related to the cognitive and 
behavioral impairments in surviving preterm infants. 
Tomiyasu et al. ( Tomiyasu et al., 2017 ) measured in-vivo 
GABA levels using 3T MEGA-PRESS (TE = 69 ms, TR = 1500 ms, 
bandwidth = 1200 Hz, 128 signal averages) in the basal ganglia and 
cerebellum of 38 neonates of which 28 were born between 23 and 36 
weeks GA (scanned between 35 and 41 weeks PMA); and the remain- 
ing 10 were term infants (scanned between 38 and 43 weeks PMA). 
The neonatal scans were performed under thiopental sedation and the 
measured basal ganglia and cerebellar GABA + /water ratios were signif- 
icantly lower ( p < 0.001) than 12 control children (range 6–16 years). 
Similarly, GABA + /Cr ratios were significantly lower in the basal ganglia 
( p = 0.001), but were higher in the cerebellum ( p = 0.006) of neonates 
compared to the control children; which was speculated by authors to 
be due to lower Cr concentrations in the neonatal cerebellum. The nor- 
malized GABA + levels were significantly lower in neonates than in chil- 
dren in both regions, regardless of the approach employed ( p < 0.01). 
Comparisons between preterm and term neonates were not reported and 
therefore the effect of prematurity remained unclear. 
Tanifuji et al. ( Tanifuji et al., 2017 ) performed 1 H-MRS at 37–46 
week PMA (period A) and 64–73 week PMA (period B) in 20 preterm 
infants (GA range 24–34 weeks). GABA was measured using the edited 
MEGA-PRESS sequence (TE = 68 ms, TR = 1500 ms, 256 signal averages) 
while Glx was measured by the unedited PRESS sequence. They reported 
that right basal ganglia GABA concentrations remained unchanged be- 
tween 1.06 (1.0–1.4) at period A to 1.13 (0.93–1.55) at period B ( p = NS); 
whereas Glx demonstrated significant increase from 3.7 (3.54–4.7) to 
6.7 (5.9–7.3), ( p < 0.01) during this period. GABA/Cr ratio decreased sig- 
nificantly at period B ( p = 0.03), but there was no significant difference 
in GABA/Cho ratios ( p = 0.58). Both Glx/Cr and Glx/Cho ratios were sig- 
nificantly increased ( p < 0.01) at period B. The authors speculated that 
the stable GABA and GABA/Cho levels indicate unchanged levels be- 
tween period A and B; and the observed decrease in the GABA/Cr ratio 
may be driven by more rapidly increasing Cr levels with brain growth. 
We recently reported early postnatal profiles of in vivo GABA and 
glutamate concentrations in the developing right frontal brain of 38 very 
preterm infants without structural brain injury [median GA of 28.0 (IQR 
26.0, 28.9) weeks; 19 males (50%)]. ( SK Basu et al., 2020 ) Non-sedated 
1 H-MRS MEGA-PRESS sequences (TE = 68 ms, TR = 2000 ms, 256 signal 
averages) were acquired at a median postmenstrual age of 38.4 (range 
33.4–46.4) weeks on a 3T scanner from a 20 mm x 15 mm x 15 mm 
(2.7 cm 3 average volume) voxel placed in the right frontal lobe mostly 
encompassing sub-cortical white matter. GABA + concentrations were 
measured from the J-difference spectra whereas glutamate and Glx mea- 
sured from the unedited PRESS (OFF) spectra. We observed that with ad- 
vancing post-menstrual age, the concentrations of glutamate increased 
significantly ( 𝛽= 0.22, p = 0.02) whereas those of GABA + did not. Ad- 
vancing postnatal age at the time of imaging positively correlated with 
GABA + ( 𝛽= 0.06, p = 0.02) and glutamate OFF ( 𝛽= 0.11, p = 0.02) and 
Glx OFF ( 𝛽= 0.12, p = 0.04), perhaps indicating postnatal activation. 
Male infants had higher GABA + (1.66 ± 0.07 vs. 1.33 ± 0.11, p = 0.01) 
concentrations compared with female infants. Glutamate concentrations 
measured from the J-difference spectra moderately correlated with mea- 
surements from OFF spectra (Spearman correlation r = 0.54, p = 0.02); 
whereas Glx measurements had low correlation. 
Maria et al., recently used HERMES (Hadamard Encoding and Re- 
construction of MEGA-Edited Spec- troscopy) sequence on a 3T scanner 
to simultaneously measure concentrations of GABA, Glx and glutathione 
(GSH) in the brain of 18 ‘healthy’ neonates born between 29 – 41 weeks 
GA and scanned at a median 41 (39–47) weeks PMA. ( Maria et al., 
2021 ) They placed relatively larger ~ 15 cm 3 voxels (anterior cingu- 
late 31.25 × 25 × 20 mm 3 with ~70% gray matter and left thalamus 
25 × 25 × 25 mm 3 with ~ 40% gray matter) and acquired sequences at 
TE = 80 ms, TR = 2000 ms, 2 kHz receiver bandwidth, 2048 data points, 
320 averages, 90°excitation/180°refocusing pulses and 20 ms editing 
pulses at 1.9 ppm for GABA and 4.56 ppm for GSH, with VAPOR water 
suppression, with excitation frequency set at 3 ppm. Prior to performing 
tissue correction, they reported higher GABA + and Glx concentrations 
in the thalamus, which was not observed after performing tissue cor- 
rection (assuming equal metabolite concentrations in gray and white 
matter). 
6. Gaps in knowledge and future directions 
Inferences drawn from above information need to be considered with 
the understanding of the heterogeneity between imaging techniques, an- 
imal and more mature human studies, regional differences in neuronal 
activity as well as level of maturation at diiferent ages. 
6.1. Special considerations with 1 H-MRS GABA and glutamate 
measurements 
6.1.1. What are we measuring? 
In vivo 1 H-MRS measures the total concentration of GABA or glu- 
tamate within a localized brain tissue voxel; and cannot distinguish 
amongst the cytoplasmic, vesicular and extracellular pools. While it is 
presumed that the vesicular GABA or glutamate is mostly invisible to 
the 1 H-MRS, recent reports have debated this. ( Wang et al., 2013 ) Addi- 
tionally, GABA from some of these pools may be more tightly bound to 
macromolecules than others, making variable co-edited contribution to 
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the “total measured ” concentrations. Studies reporting association of be- 
havior and MRS-derived GABA, ( Hermans et al., 2018 ; CJ Stagg et al., 
2011 ; Kolasinski et al., 2019 ; CJ Stagg et al., 2011 ; Floyer-Lea et al., 
2006 ) indicate correlation with the neurotransmitter and neuromodu- 
lator GABA pool. However, in the developing brain the extra-synaptic 
GABA mediates the early neurosignalling and developmental regulation; 
and may substantially contribute to the 1 H-MRS GABA signal. It re- 
mains unclear if the observed differences in 1 H-MRS measured GABA 
and glutamate concentrations reflect a global change or a selective 
change in a specific pool and/or changes in co-edited macromolecules. 
( Bell et al., 2021 ) This emphasizes the need of interpreting 1 H-MRS data 
in conjunction with other modes of in vivo investigation like connectiv- 
ity, electrophysiological studies as well as ex-vivo data using immune- 
histochemical staining to correlate functional and anatomical identifi- 
cation. 
6.1.2. Can we simultaneously measure GABA and glutamate 
concentrations? 
Given the strong metabolic, functional and developmental relation- 
ship between GABA and glutamate, their simultaneous measurement is 
essential in understanding both healthy and pathophysiologic processes 
in the developing brain. MEGA-PRESS yields most reliable measure- 
ments for GABA; ( GE Dwyer et al., 2018 ) whereas TE-averaged PRESS 
(J resolved PRESS), unedited short TE PRESS or STEAM sequences 
are used more conventionally for glutamate and glutamine measure- 
ments. ( Ramadan et al., 2013 ; Yang et al., 2008 ; C Choi et al., 2006 ; 
Hancu, 2009 ; Maddock et al., 2018 ) Recent studies have reported simul- 
taneous measurements from MEGA-PRESS sequences, reporting GABA 
from the J-edited and glutamate (and/or Glx) from both the J-edited 
as well as the more conventional unedited PRESS with fair correlation. 
( O’Gorman et al., 2011 ; Gao et al., 2013 ; Maddock et al., 2018 ; AD Har- 
ris et al., 2017 ; SK Basu et al., 2020 ; Maria et al., 2021 ) 
6.1.3. Are measured GABA and glutamate concentrations related to 
functional imaging parameters? 
Functional connectivity measured by blood-oxygen-level-dependent 
contrast amplitudes provides a non-invasive assessment of the devel- 
opment and activation status of the neural circuits, which is func- 
tionally dependent on neurotransmitter balance predominantly GABA 
and glutamate. In adults, studies report correlations between GABA 
and glutamate concentrations and connectivity parameters that vary 
with age, paired brain regions being investigated for connectivity, and 
state of health or disease. ( Donahue et al., 2010 ; Duncan et al., 2014 ; 
Duncan et al., 2019 ; Gonen et al., 2020 ; Gao et al., 2018 ) For exam- 
ple, seed-based functional connectivity measures of anterior cingulate 
cortex negatively correlated with GABA concentrations and a positive 
correlation with glutamate concentrations in healthy controls but not 
in individuals with neurologic disease. ( Shukla et al., 2019 ) In a re- 
port in preterm infants, Kwon et al. reported a positive correlation be- 
tween frontal GABA concentrations and intrinsic functional connectivity 
at term corrected age; whereas term-born infants demonstrated an in- 
verse correlation. ( Kwon et al., 2014 ) Prospective longitudinal studies 
with simultaneous fMRI and 1 H-MRS measurements in this population 
are needed to investigate whether this divergent correlation is related 
to their postnatal age, stage of maturation and most importantly, neuro- 
cognitive outcomes. 
6.2. Inferences based on existing data from the developing brain 
The trajectory of GABA concentrations from early childhood to late 
aging has been described by Porges et al. ( Porges et al., 2020 ) Keeping 
the above considerations in mind, we combine the neonatal data from 
animal and human studies and draw the following inferences: 
• GABA concentrations demonstrate a stable to slight upward trajec- 
tory during the early developmental phase (late gestation-early post- 
natal life) followed by a declining trend after 3–6 postnatal months. 
While this may indicate synaptogenesis and functional maturation 
followed by neuronal pruning after the first few months of life, dif- 
ferent pools contributing to the overall measured GABA + may have 
distinct trajectories. We can speculate that the overall GABA + trajec- 
tory includes increasing intra-cellular and synaptic GABA with a de- 
creasing extra-cellular GABA with maturation; further superimposed 
by the age-dependent increase in co-edited macromolecules. The ob- 
served decline in GABA/Cr ratio during infancy could be driven by 
more rapidly increasing Cr concentrations with brain growth. 
• Glutamate concentrations increase with advancing age during late 
gestation to early infancy and beyond into adolescence. This find- 
ing is consistent across animal as well as neonatal and adult hu- 
man studies and likely reflects an increase in both the intra-synaptic 
neurotransmitter component as well as the more ubiquitous extra- 
synaptic glutamate along with glutamine (measured as Glx) in cel- 
lular metabolic cycles. Since the absolute number of glutamatergic 
neurons decrease after birth due to maturational pruning, this con- 
tinuing uptrend indicates higher levels of intraneuronal glutamate 
(and glutamine) in mature neurons. 
• Regional variations in GABA and glutamate concentrations have 
been reported in adult literature, with lower GABA concentrations 
in the frontal cortex compared to parietal and occipital cortex. This 
is more pertinent for neonates since phylogenetically ancient caudal 
and midline structures mature earlier than the frontal-prefrontal re- 
gions, while premature exposure to ‘unnatural’ extra-uterine stimu- 
lus (e.g. pain, noise, light) after preterm birth may alter development 
as demonstrated by resting-state connectivity studies. ( De Asis-Cruz 
et al., 2020 ; De Asis-Cruz et al., 2015 ) GABA and glutamate con- 
centrations seem to be symmetric with little interhemispheric differ- 
ences in adult brain (no neonatal data). 
• Gray matter GABA and glutamate concentrations are higher than 
white matter concentrations in the adult brain and accordingly 
a correction factor of 0.5 is used for tissue fraction adjustment. 
( Harris et al., 2015 ) In absence of specific data from the develop- 
ing neonatal brain, we speculate that cortical gray matter GABA 
concentrations increase through late gestation and early postnatal 
life as GABA-ergic neurons reach the sub-plate and undergo further 
organizational and metabolic maturation after birth. Due to this on- 
going transition of neurons from white matter to sub-cortical plate 
to the layered neocortex, tissue correction strategies need to include 
age-specific correction factors for neonatal data especially when ac- 
quired before term-equivalent age. 
• Preterm infants have lower GABA and glutamate concentrations 
compared with age-corrected term infants. Further investigation is 
needed to explore whether this can serve as an early bio-marker of 
delayed/impaired overall development even in absence of structural 
brain injury. 
• The divergent relationship of GABA with resting state connectivity 
in preterm versus term infants reported in one study ( Kwon et al., 
2014 ) is intriguing. It remains uncertain whether it is related to 
GABA signaling shifts, migration and maturational changes as well 
as altered connectivity in preterm infants and further, its value as an 
early biomarker to predict developmental outcomes. 
These speculative inferences need prospective longitudinal in vivo 
investigation and confirmation in the preterm developing brain with 
long term follow-up for neurodevelopmental outcomes. 
6.3. Future directions for 1 H-MRS GABA and glutamate measurements in 
neonatal population 
6.3.1. Consensus recommendations for neonatal GABA-editing acquisitions 
Recent consensus expert recommendations have been published re- 
garding 1 H-MRS acquisition parameters, J-difference editing, 1 H-MRS 
reporting standards, motion correction and partial tissue correction 
based on investigations in the adult human brain. ( AD Harris et al., 
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2017 ; Andronesi et al., 2020 ; Choi et al., 2020 ; Lin et al., 2021 ; 
Wilson et al., 2019 ) While it seems logical to use the same parame- 
ters for neonatal studies, they need to be rationalized for feasibility in 
neonatal populations due to the special circumstances discussed earlier. 
For example, since the basal ganglia or thalamus volume is only 4–8 
cm 3 in term neonates (smaller in the preterm infant), ( Loh et al., 2017 ) 
a larger voxel acquisition might yield better quality spectrum, but at 
the expense of regional specificity. This is specifically pertinent to the 
neonatal brain where there is no consensus on the ratio of gray vs white 
matter levels of GABA or glutamate, with tissue correction strategies as- 
suming equal gray and white matter contributions, effectively correct- 
ing only for the CSF. Similarly, longer sequences acquiring higher aver- 
ages would improve SNR and spectral fit, but at the expense of longer 
scan duration, which in turn increases potential for motion artifact and 
adverse events in a high-risk critically ill population dependent on in- 
tensive care. Perhaps, the goal should be to acquire spectra from the 
largest possible voxel that fits in the specific region of interest and for 
the shortest duration that would yield sufficient signal averages for ac- 
ceptable spectral quality. Additional considerations include developing 
age specific brain atlases, ( Makropoulos et al., 2018 ; Glasser et al., 2016 ) 
alongwith consensus recommendations for tissue and motion correction 
strategies specific to newborns, adapted from existing adult literature. 
( Andronesi et al., 2020 ; Quadrelli et al., 2016 ) 
6.3.2. Are GABA and glutamate concentrations related to 
neurodevelopmental outcomes in premature infants? 
To date, there are no reports linking neurodevelopmental outcomes 
in preterm infants with in vivo GABA and glutamate concentrations. 
Ex-vivo infant autopsies indicate lower GABA and glutamate concentra- 
tions in the gray matter of preterm infants compared with term infants. 
Drawing parallels from the observation that lower GABA and gluta- 
mate concentrations are associated normal adult aging, lower cognition 
and neuropsychiatric conditions, it supports the hypothesis of similar 
association with neurodevelopmental impairments in preterm infants 
that needs verification by prospective studies. ( EC Porges et al., 2017 ; 
Huang et al., 2017 ) 
6.3.3. Can we integrate in vivo modalities like 1 H-MRS, resting state 
connectivity and electroencephalography for comprehensive assessment of 
the GABAergic system function? 
Electrical brain activity detected by electroencephalography (EEG), 
allows in vivo assessment of neurosignalling and has been reported to 
qualitatively and quantitatively evolve with advancing age and matura- 
tion in the preterm infants and is associated with neurodevelopmental 
outcomes. ( Pavlidis et al., 2017 ; Arora et al., 2018 ; Huning et al., 2018 ) 
Slow endogenous activity transients are mostly recorded in prenatal and 
preterm developing brain and typically diminish with advancing age, 
in parallel with functional maturation of GABAergic neurotransmission. 
( Vanhatalo et al., 2005 ) Since electrocortical signals recorded by EEG 
are dependent on GABA and glutamate (and other) neurotransmitter 
function, it may help understand their bidirectional relationship with 
clinical events (e.g., hypoxia, hypotension) and administered medica- 
tions (sedatives, opioids, caffeine) known to influence these pathways. 
( Malk et al., 2014 ) Simultaneous EEG with 1 H-MRS and MR resting state 
connectivity may further elaborate the influence of changing GABA and 
glutamate concentrations on the electrocortical maturation of the devel- 
oping brain. Investigation of neonatal population as part of the Human 
Connectome Project will facilitate understanding the timeline of nor- 
mative development of connectivity and thus may facilitate detecting 
disruptions following injury after premature birth. ( Glasser et al., 2016 ; 
Smith et al., 2013 ) 
Transcranial magnetic stimulation (TMS) is used to selectively stim- 
ulate the cortical GABA-ergic interneurons and to monitor its effect on 
function of postsynaptic fast acting ionotropic (GABA A ) and slower act- 
ing metabotropic (GABA B ) receptors by measuring the GABA induced 
short and long interval intracortical inhibition, respectively on EEG. 
( Reis et al., 2008 ; Hermans et al., 2018 ) TMS studies are currently lim- 
ited to adult populations and its applications have been reviewed by 
Reis et al. ( Reis et al., 2008 ) An alternative to single-voxel 1 H-MRS is 
the chemical shift imaging (CSI or MRSI) approach which provides a 
visual representation of the metabolic milieu of a brain slice. However, 
this approach has not, to our knowledge, been used in the neonatal pop- 
ulation, and may need to overcome challenges such as spatial coverage 
around excitation edges, scalp lipid contamination and increased mo- 
tion artifact contamination due to longer scan times. Integrated use of 
available in vivo modalities for future studies in preterm neonates may 
fill the existing gaps in knowledge. 
Summary 
GABA and glutamate play a vital role in fetal and neonatal brain 
development. Their developmental timeline becomes more pertinent in 
preterm infants whose developing brains are prematurely exposed to 
the extra uterine stress and predisposed to neurological disorders, per- 
haps in part as sequelae of early derangements in GABA and glutamate 
systems. Despite the technical challenges, neonatal 1 H-MRS measure- 
ments of GABA and glutamate provide crucial information that needs 
integrated interpretation with MRI-based functional connectivity and 
EEG for comprehensive in-vivo assessment of postnatal neurophysiology 
and mechanisms of injury after preterm birth. Prospective investigation 
of the relationship of in vivo GABA and glutamate measurements with 
neurodevelopmental outcomes and clinical correlates may serve as an 
early neuroimaging outcome or biomarker for future neuroprotective 
trials. 
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